Post-transplant outcomes after intensive chemotherapy versus hypomethylating agent/venetoclax in acute myeloid leukemia

Blood Neoplasia · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles